|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 31/495 | (2006.01) | ||
| C07D 487/08 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 2037922 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07798915.0 |
| Date of filing the European patent application | 2007-06-22 | |
| (97) | Date of publication of the European application | 2009-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-22 |
| (46) | Date of publication of the claims translation | 2014-05-26 |
| (86) | Number | PCT/US2007/071854 |
| Date | 2007-06-22 |
| (87) | Number | WO 2007/150011 |
| Date | 2007-12-27 |
| (30) | Number | Date | Country code |
| 805602 P | 2006-06-23 | US |
| (72) |
DUFFY, Kevin, J., US
FITCH, Duke, M., US
JIN, Jian, US
LIU, Ronggang, US
SHAW, Antony, N., US
WIGGALL, Kenneth, US
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centreville Road, Suite 400,, Wilmington, Delaware 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prolil-hidroksidazės inhibitoriai |
| PROLYL HYDROXYLASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2024-05-21 | 18 | 347.00 EUR |
| 2025-06-22 |